| answer text |
<p>Cannabis is naturally occurring plant and a Class B controlled drug; one of the
main active chemicals in cannabis is tetrahydrocannabinol (THC). Cannabis is not a
medicinal product and is not licensed as a medicine in the United Kingdom and the
Government has no plans to legalise raw cannabis for medicinal purposes, as cannabis
has a number of acute and chronic health effects, such the possibility of developing
mental health problems or harming the lungs when smoked.</p><p> </p><p>Since 2010
two applications for research funding into medicinal cannabis have been made to National
Institute for Health Research (NIHR) Research Programmes. Of these one, within the
Research for Patient Benefit (RfPB) Programme, has been accepted.</p><p> </p><p>The
NIHR also provides support and facilities for research by funding a range of infrastructure
facilities. Since 2010 seven projects related to medicinal cannabis have been supported
through the NIHR infrastructure; however it is not possible to ascertain the number
of applications received as the Department, and our managing agent, does not record
this information.</p><p><strong> </strong></p><p>Between April 2010 and March 2014
the Medical Research Council received four applications for funding for research that
related to the medicinal cannabis products. Of these four applications, two were successful.</p><p><strong>
</strong></p><p><strong> </strong></p><p> </p>
|
|
